DJ Khaled Opens Up His “Walk, Golf, and Wegovy” Routine in New Novo Campaign

1 week ago 12

The producer is sharing a year of weight management, fatherhood and daily discipline as the face of a new behind-the-scenes partnership.

DJ Khaled is letting fans behind the scenes of the routine he credits with changing his health. Novo Nordisk has announced a partnership with Khaled for Wegovy (semaglutide), built around what the campaign calls his real-life “Walk, Golf, and Wegovy” diet and weight-loss routine. According to the company, Khaled has been taking Wegovy for weight management since late 2025, and he will now share his experience publicly, covering weight loss and fatherhood, his real-life diet and exercise routine, and the moment he knew it was time to talk to his doctor about treatment. This story is a brand campaign story: the health claims below are Khaled’s personal account and the company’s statements, attributed as such, and individual results vary.

Khaled put his own numbers on the record. “I’m sharing more of my routine and the consistency that’s getting results,” he said. “I’ve been taking Wegovy for a year now and lost 75 pounds, or about 25% of my body weight. My progress, it’s something I’m proud of — not just for myself, but what taking these steps means for my family. Being a father, being a husband, doing this for the people who depend on me — that’s the real major key. I’m grateful for the journey, grateful for my family, and grateful to share this chapter with the people who’ve supported me from day one.” That framing — family first, consistency over spectacle — is the campaign’s center of gravity.

Why He Says He Started, in His Own Words

In a question-and-answer exchange released with the announcement, Khaled said the turning point came about a year ago while he was performing. He said the extra weight he was carrying was affecting his performance, and that a friend calling it out helped convince him he needed a change. He said he was already putting in work through walking and golf, but that the combination alone did not get the result he wanted, so he talked to his doctor. Now, he said, alongside a healthy diet, the routine is “walk, golf, and Wegovy.”

He also explained why he is going public now. Khaled said fans had already noticed the change, with comments, speculation and support following him, and that he wanted to be direct with them and remove any shame from taking care of his weight. He noted that he turned 50 last year and described this period as a new chapter of goals, wins and blessings, with managing his weight as part of it. His advice, as stated in the campaign, is for anyone considering Wegovy to talk to their doctor and figure out what is best for them.

The company presents the partnership as a broader push to spotlight lived experiences with the medicine and encourage open conversation about weight-management medication. The collaboration follows Khaled’s earlier work with Novo on the Wegovy commercial that aired during the 2026 big game, which independent advertising and news coverage at the time also documented, with Khaled appearing alongside other well-known faces in a star-studded spot for the Wegovy pill. “This collaboration represents a new way for us to connect with people who are navigating their own health experiences. DJ Khaled speaks directly to millions of people with honesty and energy, and we’re proud that he’s chosen to share something as personal as his experience with Wegovy,” said Ed Cinca, senior vice president, Marketing and Patient Solutions at Novo. “We think his story will go a long way in helping people who are thinking about weight-management options to talk with a healthcare professional about the best treatment to help them lose weight and keep it off.”

What the Company Says About the Medicine — and the Limits

Novo describes Wegovy (semaglutide) injection 2.4 mg as a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with excess weight who also have weight-related medical problems, to lose weight and keep it off. The company also states that Wegovy is FDA-approved to reduce the risk of major cardiovascular events such as death, heart attack or stroke in adults with known heart disease and with either obesity or overweight. Those are the company’s approved-use descriptions, not a recommendation for any individual reader.

The campaign materials include study context, again attributed to the company. Novo states that this was Khaled’s personal experience and that individual results may vary, and it cites a 68-week medical study of 1,961 adults living with obesity or excess weight with a related medical problem, in which adults taking the Wegovy 2.4 mg pen with diet and exercise lost an average of 15% of body weight, compared with about 2.5% on placebo. The release also carries extensive safety information, including a boxed warning about possible thyroid tumors, a list of people who should not use the medicine, and common side effects such as nausea, diarrhea and vomiting. Anyone considering prescription weight-management treatment is directed by the company to its prescribing information and to a conversation with a healthcare professional.

Why Khaled, and why now, is a marketing question as much as a health one. Weight-management medicines are now mass-culture products, advertised during the biggest television event of the year, and Novo has repeatedly chosen entertainers who talk about weight in the language of discipline rather than shame. Khaled is unusually well suited to that message: his public brand is built on repetition, routine and catchphrases about keys to success, and walking and golf were already part of his visible daily life before any partnership. The campaign simply adds a third, medical element to a routine his audience had already watched him perform.

The behind-the-scenes content now rolling out will test whether that candor holds. Khaled is promising the day-to-day version — the diet, the exercise, the fatherhood stakes — rather than a before-and-after poster. For a Wellness audience, the responsible takeaway is the narrow one the campaign itself states: a famous patient is describing his own experience, attributing his progress to a combination of diet, activity and a prescription medicine he discussed with his doctor, and urging anyone interested to have the same conversation with theirs. Nothing in the announcement promises that his result is typical, and the company says so explicitly.

Fans can find more information about the partnership at the campaign page listed in the announcement. The major key, in Khaled’s telling, is not the medicine alone. It is the walk, the golf, the consistency — and, he says, doing it for the people who depend on him.

Source: Novo Nordisk via PR Newswire, November 12, 2026; additional context from Reuters and Campaign coverage of Novo Nordisk’s 2026 big game Wegovy advertising.

The post DJ Khaled Opens Up His “Walk, Golf, and Wegovy” Routine in New Novo Campaign appeared first on The Hype Magazine.

Read Entire Article